arrow
B

Belén Pérez

Autonomous University of Barcelona
H指数:32
被引数:2,878

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Topliss-Guided Optimization of Acetanilide-Based Soluble Epoxide Hydrolase Inhibitors: Exploring the Pentafluorosulfanyl Group as a Potency-Enhancing Motif

托普利斯指导下的乙酰苯胺类可溶性环氧水解酶抑制剂的优化:探索五氟硫基团作为增强活性的基序

2026-09-070
OAAI
Perivascular adipose tissue modulates aortic reactivity in Marfan syndrome mice in a sex- and region-specific manner: Redox-dependent anticontractile effects in the female ascending aorta

血管周围脂肪组织以性别和区域特异性方式调节马凡综合征小鼠的主动脉反应性:氧化还原依赖性的抗收缩效应在雌性升主动脉中

2026-05-230
OAAI
Synthesis and Biological Profiling of New 1,2,3,4-Tetrahydrobenzo[h]naphthyridine-Based Hybrids as Dual Inhibitors of β-Amyloid and Tau Aggregation with Anticholinesterase Activity

基于1,2,3,4-四氢苯并[h]萘啶的新型杂合物的合成及其生物表征:作为具有抗胆碱酯酶活性的β-淀粉样蛋白和Tau聚集的双抑制剂

2026-04-160
OAAI
Polyfunctionalized N-Arylsulfonyl Indoles: Identification of (E)-N-Hydroxy-3-{3-[(5-(3-(piperidin-1-yl)propoxy]-1H-indol-1-yl)sulfonyl]phenyl}acrylamide (MTP150) for the Epigenetic-based Therapy of Parkinson’s Disease

多官能化N-芳基磺酰基吲哚:用于表观遗传学基础治疗帕金森病的(E)-N-羟基-3-{3-[(5-(3-(哌啶-1-基)丙氧基)-1H-吲哚-1-基)磺酰基]苯基}丙烯酰胺(MTP150)的鉴定

2026-03-310
OAAI
Dimethoxybenzohomoadamantane-based soluble epoxide hydrolase inhibitors: in vivo efficacy in a murine model of chemotherapy-induced neuropathic pain

基于Dimethoxybenzohomoadamantane的溶血性环氧水合酶抑制剂:在化疗诱导的神经病理性疼痛小鼠模型中的体内疗效

2025-12-310
PRE
Sex-and age-dependent neurovascular abnormalities linked to neuroinflammation lead to exacerbated post-ischemic brain injury in Marfan syndrome mice

与神经炎症相关的性別和年龄依赖性神经血管异常导致馬凡综合征小鼠缺血后脑损伤加重

2025-06-010
OA
Contilisant plus Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases
2024-09-100
PRE
Electronegative LDL Is Associated with Plaque Vulnerability in Patients with Ischemic Stroke and Carotid Atherosclerosis
2023-02-108
OAAI
Synthesis, In Vitro Profiling, and In Vivo Evaluation of Benzohomoadamantane-Based Ureas for Visceral Pain: A New Indication for Soluble Epoxide Hydrolase Inhibitors
2022-10-126
OAAI